(Q84480135)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19713153%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Less is more: therapeutic exon skipping for Duchenne muscular dystrophy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19713153%20AND%20SRC:MED&resulttype=core&format=json

Duchenne muscular dystrophy

6 February 2020

main subject

1 reference

inferred from title

author

Annemieke Aartsma-Rus

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19713153%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Gert-Jan B van Ommen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19713153%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

25 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19713153%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19713153%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19713153%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19713153%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

873-875

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19713153%20AND%20SRC:MED&resulttype=core&format=json

An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

Local dystrophin restoration with antisense oligonucleotide PRO051

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

Skipping toward personalized molecular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

Assessment of the feasibility of exon 45-55 multiexon skipping for Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970229-7

7 January 2021

10.1016/S1474-4422(09)70229-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19713153%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference